WINT
USDWindtree Therapeutics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$0.648
Haut
$0.650
Bas
$0.600
Volume
1.29M
Fondamentaux de l'Entreprise
Capitalisation Boursière
2.3M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
4.53M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Windtree Receives Offer for Its Preclinical Oncology Drug Candidate
Company to receive $7.0 million up front for its preclinical oncology drug candidate Up to $130.0 million in milestone payments starting with initiation of Phase 1 High single digit royalties that could total up to
Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors
Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced the appointment of Saundra Pelletier, CEO of Evofem Biosciences, Inc.
Windtree Announces Plan for Cryptocurrency Treasury Policy
WARRINGTON, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing
Windtree Therapeutics Announces Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025
Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is another step progressing to the istaroxime cardiogenic shock
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.